-transparent.png){kind=logo}
Acute pretreatment with either a Type A monoamine oxidase inhibitor (MAOI), clorgyline, or a Type B MAOI, pargyline, markedly reduced the dose of phenylethylamine (PEA) required to produce checking and a variety of other behavioral changes in rhesus monkeys. Doses of PEA (5 or 10 mg/kg) which previously were without effect, now produced significant behavioral changes in pretreatment animals.
Related Publications
R A Staub, and
J C Gillin, and
R J Wyatt
December 2012,
The American journal of psychiatry,
R A Staub, and
J C Gillin, and
R J Wyatt
May 1981,
Clinical genetics,
R A Staub, and
J C Gillin, and
R J Wyatt
October 1960,
Biochemical pharmacology,
R A Staub, and
J C Gillin, and
R J Wyatt
June 1978,
Archives internationales de pharmacodynamie et de therapie,
R A Staub, and
J C Gillin, and
R J Wyatt
December 1963,
Lancet (London, England),
R A Staub, and
J C Gillin, and
R J Wyatt
August 1964,
Lancet (London, England),
R A Staub, and
J C Gillin, and
R J Wyatt
July 1964,
Lancet (London, England),
R A Staub, and
J C Gillin, and
R J Wyatt
March 1966,
Pharmacological reviews,
R A Staub, and
J C Gillin, and
R J Wyatt
September 1964,
Lancet (London, England),
R A Staub, and
J C Gillin, and
R J Wyatt
January 1986,
Advances in neurology,
